Factors determining acceptance of coronavirus vaccine in diabetics at the endocrinology unit of Joseph Raseta Befelatanana Hospital
DOI:
https://doi.org/10.18203/2320-6012.ijrms20250955Keywords:
Coronavirus, Diabetes mellitus, Primary prevention, VaccinationAbstract
Background: Since the advent of the COVID-19 pandemic, diabetics have been categorized as being at risk of severe disease, and should benefit from vaccination to prevent the onset of severe disease and excess mortality. However, various studies reported limited participation of diabetic patients in vaccination. The aim of this study was to assess diabetic’s understanding and practices regarding vaccination against COVID-19 and the determining factors.
Methods: This was a cross-sectional study conducted over a 6-month period. Diabetic outpatients and inpatients who were able to answer our questions and who had given informed consent were invited to participate. Patients unable to complete the survey were excluded from the study.
Results: One hundred patients from the 110 diabetics included were retained, giving a participation rate of 90.9%. The median age of participants was 58.4 years (IQR: 19-85), with a sex ratio of 1.04. The positive determining factors significantly linked to participation in vaccination were the attainment of a university degree (p=0.04), confidence in the vaccine (p=0.02), and the presence of a personal history of infection or of being around COVID-19. Reasons for refusing vaccination included fear of the vaccine (88%) and of its adverse effects (80%).
Conclusions: This study suggests the need to prioritize strategies focused on improving the level of information, education and knowledge of patients regarding the severity of coronavirus disease and the importance of vaccination.
Metrics
References
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727‑33. DOI: https://doi.org/10.1056/NEJMoa2001017
Umakanthan S, Sahu P, Ranade AV, Bukelo MM, Rao JS, Abrahao-Machado LF, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96(1142):753‑8. DOI: https://doi.org/10.1136/postgradmedj-2020-138234
Parohan M, Yaghoubi S, Seraji A, Javanbakht MH, Sarraf P, Djalali M. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020;23(5):1416‑24. DOI: https://doi.org/10.1080/13685538.2020.1774748
Zhou L, Ayeh SK, Chidambaram V, Karakousis PC. Modes of transmission of SARS-CoV-2 and evidence for preventive behavioral interventions. BMC Infect Dis. 2021;21(1):496. DOI: https://doi.org/10.1186/s12879-021-06222-4
Aldossari KK, Alharbi MB, Alkahtani SM, Alrowaily TZ, Alshaikhi AM, Twair AA. COVID-19 vaccine hesitancy among patients with diabetes in Saudi Arabia. Diabetes Metab Syndr Clin Res Rev. 2021;15(5):102271. DOI: https://doi.org/10.1016/j.dsx.2021.102271
Guaraldi F, Montalti M, Di Valerio Z, Mannucci E, Nreu B, Monami M, et al. Rate and Predictors of Hesitancy toward SARS-CoV-2 vaccine among type 2 diabetic patients: results from an Italian survey. Vaccines. 2021;9(5):460.
Mbaya AL, Amisi CM. Epidemiological, clinical profile and risk factors of diabetes mellitus. Case of the Provincial General Reference Hospital of Kinshasa. Congo Res Papers. 2021;1(7):98-115.
Bayle F. Assessment of knowledge, attitudes and practices of residents of Oremu, Vaiare and Rimatara regarding vaccination against COVID-19. 2025.
World Health Organization. WHO Sage’s roadmap for setting priorities for the use of covid-19 vaccines in a limited supply context. Version 1. 2020
Ouattara Epse Soro TR, Abodo JR, Yao A, Danho J, Hué A, N’Guessan A, et al. Factors of vaccine hesitancy against COVID-19 among diabetic patients in Abidjan, Ivory Coast. Metab Dis Med. 2023;17(2):189‑95. DOI: https://doi.org/10.1016/j.mmm.2022.09.013
Guaraldi F, Montalti M, Di Valerio Z, Mannucci E, Nreu B, Monami M, et al. Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey. Vaccines. 2021;9(5):460. DOI: https://doi.org/10.3390/vaccines9050460
Navarre C, Roy P, Ledochowski S, Fabre M, Esparcieux A, Issartel B, et al. Determinants of COVID-19 vaccine hesitancy in French hospitals. Infect Dis Now. 2021;51(8):647‑53. DOI: https://doi.org/10.1016/j.idnow.2021.08.004
Lu D, Gao Y, Qi X, Li A, Zhang J. The COVID-19 vaccination hesitancy among Chinese individuals with diabetes and the impact on glycemic control of vaccination: a questionnaire study. BMC Endocr Disord. 2022;22(1):329. DOI: https://doi.org/10.1186/s12902-022-01201-5
Raut A, Samad A, Verma J, Kshirsagar P. Acceptance, hesitancy and refusal towards COVID-19 vaccination. Clin Epidemiol Glob Health. 2023;21:101283. DOI: https://doi.org/10.1016/j.cegh.2023.101283
Downloads
Published
How to Cite
Issue
Section
